Retinal Tissue Restored in Patients with Dry AMD, Heralding Paradigm Shift

Retinal tissue has been regrown in three patients with age-related macular degeneration (AMD) with geographic atrophy or dry (atrophic) AMD in a Phase I/IIa study conducted by Lineage Cell Therapeutics. “This has the potential to offer a whole new paradigm to treat the disease,” Brian Culley, CEO of Lineage, told BioSpace.
Read more: https://www.biospace.com/article/retinal-tissue-restored-in-patients-with-dry-amd-heralding-paradigm-shift/?source=Snapzu